Shorter breast radiation for early breast cancer
Part of Cancer, Skin clinical trials.
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 45 or older (or 40–44 only if you don’t have other risk factors).
- Your breast cancer is either ductal carcinoma in situ (DCIS) or invasive ductal carcinoma (IDC), not invasive lobular cancer.
- Your surgery removed the cancer with clear margins (no cancer at the edge, with a margin more than 2 mm), and lymph nodes were not involved.
- Your tumor is estrogen-receptor positive or negative (both are allowed in this study).
- Your cancer is in one place and is not multicentric or multifocal (with limited exceptions).
- You must not have had chemotherapy before radiation, must not be pregnant, and must not have certain skin/immune conditions that block radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial compares two slightly different doses of radiation (26 Gy vs 30 Gy) given in five quick sessions to just the part of the breast where cancer was removed. It is for people 50 and older with small, early-stage, non-aggressive breast cancers that are hormone positive and HER2 negative.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.